Research progress of interleukin-15 in cancer immunotherapy

M Cai, X Huang, X Huang, D Ju, YZ Zhu… - Frontiers in …, 2023 - frontiersin.org
Interleukin-15 (IL-15) is a cytokine that belongs to the interleukin-2 (IL-2) family and is
essential for the development, proliferation, and activation of immune cells, including natural …

Novel targets, novel treatments: the changing landscape of non-small cell lung cancer

D de Jong, JP Das, H Ma, J Pailey Valiplackal… - Cancers, 2023 - mdpi.com
Simple Summary Non-small cell lung cancer treatment has undergone a revolution in the
past decade owing to the discovery of mutations that drive carcinogenesis and the …

Tumor-associated macrophages: Prognostic and therapeutic targets for cancer in humans and dogs

RV Brady, DH Thamm - Frontiers in Immunology, 2023 - frontiersin.org
Macrophages are ancient, phagocytic immune cells thought to have their origins 500 million
years ago in metazoan phylogeny. The understanding of macrophages has evolved to …

Single-cell T-cell receptor repertoire profiling in dogs

MH Hoang, ZL Skidmore, H Rindt, S Chu… - Communications …, 2024 - nature.com
Spontaneous cancers in companion dogs are robust models of human disease. Tracking
tumor-specific immune responses in these models requires reagents to perform species …

Advancements in osteosarcoma management: integrating immune microenvironment insights with immunotherapeutic strategies

H Liang, M Cui, J Tu, X Chen - Frontiers in Cell and Developmental …, 2024 - frontiersin.org
Osteosarcoma, a malignant bone tumor predominantly affecting children and adolescents,
presents significant therapeutic challenges, particularly in metastatic or recurrent cases …

Translational history and hope of immunotherapy of canine tumors

JN Bryan, CA Maitz - Clinical Cancer Research, 2024 - aacrjournals.org
Companion dogs have served an important role in cancer immunotherapy research. Sharing
similar environments and diets with humans, dogs naturally develop many of the same …

Updates in osteosarcoma

JN Bryan - Veterinary Clinics: Small Animal Practice, 2024 - vetsmall.theclinics.com
Clinical care of osteosarcoma (OSA) in companion dogs has been relatively static during the
past 20 years. The disease of OSA can be described as one of “life and limb.” The limb pain …

[HTML][HTML] Comparative evaluation of tumor-infiltrating lymphocytes in companion animals: immuno-oncology as a relevant translational model for cancer therapy

CJ Pinard, A Lagree, FI Lu, J Klein, ML Oblak… - Cancers, 2022 - mdpi.com
Simple Summary Laboratory experiments studying solid tumors are limited by the inability to
adequately model the tumor microenvironment and important immune interactions. Immune …

Cancer immunotherapy

N Mason, S Dow - Therapeutic Strategies in Veterinary …, 2023 - cabidigitallibrary.org
Fig. 8.1. Cancer Immunotherapy. Page 1 Fig. 8.1. Cancer Immunotherapy. Page 2 8 Cancer
Immunotherapy NICOLA MASON 1* AND STEVEN DOW 2* 1University of Pennsylvania …

Improving osteosarcoma treatment: comparative oncology in action

L Tarone, K Mareschi, E Tirtei, D Giacobino… - Life, 2022 - mdpi.com
Osteosarcoma (OSA) is the most common pediatric malignant bone tumor. Although surgery
together with neoadjuvant/adjuvant chemotherapy has improved survival for localized OSA …